From Health Leaders Media, by Tinker Ready ...Maine seems to have made some moves over the years that allowed it to ease into in the era of mega-measurement. For one thing, the state began wrestling with quality measures more than a decade ago. In 2005, the state employee health plan began rewarding high quality hospitals … Continue reading In #Maine, transparency and cooperation lead to high #health care #quality scores
A great nation deserves a great health care system - and that means universal coverage. Everybody in, nobody out. @ShannonBrownlee #lown2017 — Lown Institute (@lowninstitute) May 5, 2017 The Lown Institute's meeting is taking place as the nation is trying to digest the possible impact of yesterday's vote in the House of Representatives. The group's … Continue reading House# AHCA vote livens up Lown2017 “right care” conference
From The Globe. A Boston jury on Monday found that a spine surgeon at Massachusetts General Hospital failed to i nform a Westwood financial analyst that he planned to operate on two patients at once, but the jury concluded that the doctor’s divided attention did not cause the man’s quadriplegia. As a result the jury … Continue reading Jury: Double-booked surgery did not lead to injury
From a recent talk at Harvard by Danielle Ofri, MD, author of What Doctors Feel. Ofri's talk centered on one emotion, shame, which she said overwhelms many doctors and is a major reason many medical errors go unaddressed. When errors are not acknowledged, even those without bad outcomes, no one learns from them, she said. … Continue reading From Health Leaders: Shame, fear and medical errors
My report from Health Leaders on a recent talk by members of Henrietta Lacks' family. The ongoing story of the late Henrietta Lacks, the African-American woman who unwittingly provided cells for years of medical research, has much to offer those battling disparities in healthcare, according to family members who spoke in Boston last week. That … Continue reading Health Leaders: #Lacks family members now have a say in #Henrietta’s immortal scientific legacy
Pharmaceutical manufacturers often look to patient advocates for help winning approval for new drugs. Their most recent success in this area was the FDA’s approval of a new drug for Duchenne muscular dystrophy. That decision came despite recommendations against approval from FDA staff. In an editorial, the Boston Globe questioned the FDA’s move while noting … Continue reading Two Boston meetings look at the role of patient advocates. They offer two very different perspectives.
The Globe offers a peek at the drug company marketing/meals at smaller hospitals Years after many big academic medical centers cracked down on industry perks, drug companies still regularly buy meals for doctors affiliated with smaller hospitals, a new analysis shows, with some physicians receiving dozens of lunches and dinners in a single year. At a number … Continue reading #Massachusetts cares if #doctors have conflicts of interest, but do #patients care?